First report of post-transplant autoimmune hepatitis recurrence following SARS-CoV-2 mRNA vaccination

Whilst vaccination for the SARS-CoV-2 virus has been successful in reducing the severity and burden of the COVID-19 pandemic, there have been recent reports of mRNA vaccines triggering autoimmune hepatitis in the native liver. There have been no descriptions thus far of recurrent ‘autoimmune hepatit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahalingham, Aarani, Duckworth, Adam, Griffiths, William J.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977213/
https://www.ncbi.nlm.nih.gov/pubmed/35390478
http://dx.doi.org/10.1016/j.trim.2022.101600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977213/
https://www.ncbi.nlm.nih.gov/pubmed/35390478
http://dx.doi.org/10.1016/j.trim.2022.101600

Ejemplares similares